Meet our market access and reimbursement experts
MDisrupt Market Access and Reimbursement Experts
We are the experts in finding you healthcare industry experts. The key to success in building healthtech products that scale is engaging healthcare experts early and often. Explore all available experts below. We can help.
Diagnostics Executive Advisor
Wide ranging experience in cross-functional senior management, business development, startup entrepreneurship, board membership, fundraising, strategic and business planning, financial analysis, operations, product development, reimbursement, commercialization, and market access for new technologies focused on human clinical diagnostics.
- Board Advisory
- M&A Due Diligence
- Strategy Development
Chief Medical Officer
Industry thought leader specializing in the self-insured employer channel. MD/MBA/MPH with 20+ years experience in employee benefits, population health and health and productivity. Focused on new medical technologies; high cost medical/prescription claimants and; go-to-market strategies for healthcare disruptors.
- Medical Cost Containment
- Data Analytics
- Sales and Marketing Strategies
- Thought Leadership
Business & Commercial Strategist
Healthcare generalist with success in devising business models and corporate strategies in complex regulated markets. Expertise in evaluating market-need, engaging stakeholders, and building value-add partnerships.
- Market Evaluation & Competitive Analysis
- Customer & Stakeholder Profiling
- Business Structure & Strategic Operations Planning
- Needs Finding & Target Product Profile Development
Experienced advisor works with healthtech companies across a range of strategic, market access, and reimbursement topics. Passionate about leading next-generation healthtech marketplace development with the delivery of high-value health care services and building innovative systems.
- Health Economics
- Clinical Genomics
- Business Development Strategy
- Health Technology Assessment Evidentiary Needs
Chief Medical Officer
30+ yrs experience in molecular diagnostics in regional and academic medical centers, biotech startups, and the reference lab settings. Expertise extends beyond molecular diagnostics to regulatory affairs and strategic considerations.
- Molecular Diagnostics
- Regulatory Affairs
- Health Policy Trends Insights
- Executive Leadership
Experienced physician working with numerous digital health companies developing products, advancing clinical use cases, developing quality data warehouses, and supporting funding rounds to get the best products to market.
- Clinical Data Use Case Development
- Data Warehousing and Data Harmonization
- Designing for User Engagement
- Internal and External Affairs Liaison
Chief Medical Officer
An experienced molecular pathologist with extensive executive experience in the genomics and biotech industry. Expertise ranges from test development, laboratory operations, medical affairs and medical/reimbursement strategy including being an accomplished communicator.
- Medical/Scientific Strategy
- Evidence Development
- Reimbursement Strategy
- Genomic Medicine
Find Your Expert
Whether your company is early-stage or well-established, we connect you to the expertise you need to accelerate your health product’s path to market.
Legal and Health Policy
Market Access and Reimbursment
Regulatory and Compliance
Join Us! Become an MDisruptor.
At MDisrupt, we match practicing health professionals to healthtech companies seeking to build clinically and commercially viable products. We handle the details, allowing you to do what you do best.
- Regulatory Experts
- Health Economists
- Lab Test Designers
- Market Access Experts
- Commercial Strategist
- Clinical Trial Designers
- Expert in Residence
- Strategic Advisor
- Key Opinion Leadership
- Advisory Boards
- Focus Groups
- Consulting Projects
Check out our blog
Digital health has so much potential—we can’t alienate doctors from it, because it’s the future. If physicians and digital health teams work together, we can make these products all the more robust and meaningful for patients.
“We know that the way we are spending money in healthcare is not working. So everything will change into value-based care and precision medicine will play a critical role there.”
“Without significant changes, the genetic data we use to create the next generation of diagnostics, disease risk assessments, and therapeutic interventions will continue to make precision medicine available only to those of European descent.”